Secured an award of $212,000.00 against the administrator of an estate who wrongfully converted the decedent’s assets to her own. Secured a permanent injunction on behalf of a homeowners association, enforcing deed restriction prohibiting a business in a residential neighborhood. Jackson’s Ridge Homeowner’s Association v. Successfully defended purchaser of real property where a dispute arose as to whether the sale was proper. Secured an Order directing the defendant bank to place $1.16 Million in trust to cover anticipated damages awards. He was previously Vice Chancellor of Brunel University in the UK and of Murdoch University in Western Australia. Vice president, member of the Board of Directors, Congregation Beth Sholom Steven Schwartz AM (/ w r t s / born 5 November 1946) is an American and Australian academic and, until late 2012, the Vice Chancellor of Macquarie University in Sydney, Australia. Vice President, member of the Board of Directors, Kent County SPCA Rutgers University School of Law, Camden, NJ Steven Schwartz, M.D., is an ophthalmologist whose primary research areas include early diagnosis and treatment of diseases such as macular degeneration, retinopathy of prematurity and diabetic eye disease. Temple University, Master of Arts in Physics Temple University, Bachelor of Arts in Physics United States District Court for Delaware Other Areas of Practice (less than 10% of practice is devoted to the following): Primary Areas of Practice (90% or more of Steve’s practice is devoted to the following): Steven maintains primary responsibility for the firm’s real estate litigation, corporate and business litigation, and Court of Chancery practice.Įmail: Steven sees clients in the Dover office He is the founder and senior partner of the firm. Steven was admitted to practice law in Delaware in 1974. In 1974 he obtained his JD from Rutgers University School of Law in Camden, New Jersey. Steven holds undergraduate and masters degrees in physics from Temple University. He moved from New Jersey to Delaware in 1967 to teach physics and calculus at Wesley College in Dover. Schwartz led two new clinical trials testing the use of stem cell-derived retinal pigment epithelial cells to address vision loss in people suffering from Stargardt's macular dystrophy and dry age-related macular degeneration.Steven Schwartz was a college professor before attending law school. Schwartz is dedicated to improving both the quality of and access to specialized ophthalmology care. Through innovative teleophthalmological approaches to screen for eye diseases (such as diabetic retinopathy and ROP), Dr.
Schwartz’ clinical research focuses on trials of novel pharmacotherapeutic agents to discover treatments for both wet and dry age-related macular degeneration, ROP, and diabetic retinopathy.
Additionally, his focus includes development and evaluation of novel medical device technologies, imaging technologies, surgical equipment (including surgical robots), and drug delivery systems, with particular emphasis on diagnostic and treatment applications. Schwartz’ primary areas of research include early diagnosis and treatment of diseases such as macular degeneration, retinopathy of prematurity (ROP), and diabetic eye disease. David Geffen School of Medicine at UCLAĭr.
#STEVEN SCHWARTZ PROFESSIONAL#
Professional Affiliations Academic Appointments
0 kommentar(er)
